|

Heart Disease Clinical Trials in New Jersey

95 recruiting studies across 54 cities

All Trials in New Jersey

Phase
Trial Phase Location
A Study of Blood Pressure Control During Cancer TreatmentPhase 2Basking Ridge
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Bridgewater
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3Bridgewater
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Bridgewater
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Bridgewater
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Bridgewater
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Bridgewater
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Bridgewater
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Bridgewater
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Bridgewater
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/ABrowns Mills
Alleviant ALLAY-HFrEF StudyN/ABrowns Mills
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3Browns Mills
CCM OPEN HF Registry—Browns Mills
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmN/ABrowns Mills
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/ABrowns Mills
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 3Camden
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial FibrillationPhase 2Camden
Assessment of CCM in HF With Higher Ejection FractionN/ACamden
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/ACamden
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)N/ACamden
Prevail Global StudyN/ACamden
Product Surveillance Registry—Camden
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/ACamden
Transfusion Requirements in Younger Patients Undergoing Cardiac SurgeryN/ACamden
Behavioral Exposure for Introceptive Tolerance RCTN/AEast Brunswick
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Eatontown
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Eatontown
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Eatontown
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Edison
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)N/AEdison
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedPhase 2Elizabeth
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Elmer
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Elmer
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/AEnglewood
One-Month DAPT in CABG PatientsPhase 3Englewood
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - MinoritiesPhase 3Englewood
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - WomenPhase 3Englewood
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/AFlemington
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Flemington
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/AFreehold
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Hackensack
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—Hackensack
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor—Hackensack
Cardiogenic Shock Working Group Registry—Hackensack
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/AHackensack
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Hackensack
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/AHackensack
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment—Hackensack
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryN/AHackensack
Left vs Left Randomized Clinical TrialN/AHackensack
Pivotal Study for the Cardiac Performance System (CPS)—Hackensack
The Fourth Left Atrial Appendage Occlusion StudyN/AHackensack
The HEARTFELT StudyN/AHackensack
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/AHackensack
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3Phase 3Haddon Heights
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Haddon Heights
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)N/AJersey City
IVUS CHIP UPP Registry—Jersey City
SuperSaturated Oxygen Comprehensive Observational Registry—Jersey City
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure—Marlton
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesN/AMorristown
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveN/AMorristown
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPhase 2Morristown
ATLAS (AltaValve) Pivotal TrialN/AMorristown
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity—Morristown
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry—Morristown
Early Feasibility Study - Edwards APTURE Transcatheter Shunt SystemN/AMorristown
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/AMorristown
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR—Morristown
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Morristown
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/AMorristown
TVMR With the INNOVALVE System Trial - Early Feasibility StudyN/AMorristown
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/AMorristown
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Neptune City
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Neptune City
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3New Brunswick
Abbott Structural Heart Device Registry—New Brunswick
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3New Brunswick
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting—New Brunswick
The Salt Study for Heart FailureN/ANew Brunswick
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/ANewark
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPhase 3Newark
PARTNER 3 Trial - Aortic Valve-in-ValveN/ANewark
Reducing Risk for Infective EndocarditisN/ANewark
Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA—Paramus
Rutgers University Study of the Genetics of Pulmonary Hypertension—Piscataway
Foundational Programs to Combat Clinician StressN/APlainsboro
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/APomona
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small VesselsN/APomona
His-Bundle Corrective Pacing in Heart FailureN/ARidgewood
Renal Denervation + PVI vs PVI Alone for Persistent AFN/AShort Hills
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPhase 2Summit
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyN/AVoorhees Township
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide—Whippany

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.